ID

23694

Descripción

Effect of Dutasteride on Androgen-Response Gene Expression in Patients With Advanced Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00668642

Link

https://clinicaltrials.gov/show/NCT00668642

Palabras clave

  1. 10/7/17 10/7/17 -
Subido en

10 de julio de 2017

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Prostate Cancer NCT00668642

Eligibility Prostate Cancer NCT00668642

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologically proven prostate cancer
Descripción

ID.1

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007112
patients are hormone-naive
Descripción

ID.2

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0019932
patients either to begin androgen ablation therapy with lhrh agonist or already receiving therapy with lhrh agonist
Descripción

ID.3

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1298673
advanced prostate cancer with either positive pelvic nodes or bone/visceral metastasis
Descripción

ID.4

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0376358
UMLS CUI [1,2]
C0027627
must have an intact prostate (no previous surgery or xrt)
Descripción

ID.5

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0033572
UMLS CUI [1,2]
C0436209
UMLS CUI [1,3]
C0038895
ecog performance status 0-2
Descripción

ID.6

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1520224
recovery from any major infection or surgical procedure
Descripción

ID.7

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0543467
UMLS CUI [1,2]
C2004454
UMLS CUI [1,3]
C3714514
signed informed consent
Descripción

ID.8

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
known intolerance or allergy to dutasteride
Descripción

ID.9

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0754659
concomitant chemotherapy, biologic therapy, or xrt to prostate
Descripción

ID.10

Tipo de datos

boolean

bilateral orchiectomy
Descripción

ID.11

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0007347
prior malignancy within 5 years of registration
Descripción

ID.12

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0455471

Similar models

Eligibility Prostate Cancer NCT00668642

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
ID.1
Item
histologically proven prostate cancer
boolean
C0007112 (UMLS CUI [1])
ID.2
Item
patients are hormone-naive
boolean
C0019932 (UMLS CUI [1])
ID.3
Item
patients either to begin androgen ablation therapy with lhrh agonist or already receiving therapy with lhrh agonist
boolean
C1298673 (UMLS CUI [1])
ID.4
Item
advanced prostate cancer with either positive pelvic nodes or bone/visceral metastasis
boolean
C0376358 (UMLS CUI [1,1])
C0027627 (UMLS CUI [1,2])
ID.5
Item
must have an intact prostate (no previous surgery or xrt)
boolean
C0033572 (UMLS CUI [1,1])
C0436209 (UMLS CUI [1,2])
C0038895 (UMLS CUI [1,3])
ID.6
Item
ecog performance status 0-2
boolean
C1520224 (UMLS CUI [1])
ID.7
Item
recovery from any major infection or surgical procedure
boolean
C0543467 (UMLS CUI [1,1])
C2004454 (UMLS CUI [1,2])
C3714514 (UMLS CUI [1,3])
ID.8
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
ID.9
Item
known intolerance or allergy to dutasteride
boolean
C0020517 (UMLS CUI [1,1])
C0754659 (UMLS CUI [1,2])
ID.10
Item
concomitant chemotherapy, biologic therapy, or xrt to prostate
boolean
ID.11
Item
bilateral orchiectomy
boolean
C0007347 (UMLS CUI [1])
ID.12
Item
prior malignancy within 5 years of registration
boolean
C0455471 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial